Skip to Main Content

Paper Details

Doxorubicin-resistant pleomorphic liposarcoma with PDGFRA gene amplification is targeted and regressed by pazopanib in a patient-derived orthotopic xenograft mouse model.
Tissue Cell
13
2018
DOX, Doxorubicin, Doxorubicin-resistant, PAZ, PDGFRA, PDGFRA gene, PDGFRA-amplified PLPS, PDOX, PDOX model, PDOX tumors, PLPS, PLPS PDOX, Pleomorphic liposarcoma, TEM, doxorubicin, mouse, nude mice, patient, patients, pazopanib, pleomorphic liposarcoma, temozolomide, tumors
Author NameAffiliation
Scott D NelsonUniversity of California los angeles
Sarah M DryUniversity of California los angeles
Arun S SinghUniversity of California los angeles
Fritz C EilberUniversity of California los angeles
Robert M HoffmanAntiCancer Inc., University of California
  • 1 - 5

Datasets

Release 1.2